Arax Advisory Partners’s Tevogen Bio Holdings TVGN Stock Holding History

Arax Advisory Partners’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2	Closed	-$69	–	4582
2025 Q3	$69	Buy	+2	New	+$98	﹤0.01%	3522

Other funds holding TVGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Arax Advisory Partners's TVGN Position: Q4 2025 in Review

Arax Advisory Partners sold out of Tevogen Bio Holdings (TVGN) in Q4 2025, closing a stake of 2 shares — an estimated $69 sold.

Arax Advisory Partners first reported a position in TVGN in Q3 2025 and held it in 1 quarter. The position peaked at $69 in Q3 2025. 51 funds tracked by Wall St. Rank hold TVGN as of Q4 2025.

Arax Advisory Partners reported no remaining Tevogen Bio Holdings position as of Q4 2025 after selling out during the quarter.
Arax Advisory Partners sold 2 Tevogen Bio Holdings shares in Q4 2025, an estimated $69.
Arax Advisory Partners first reported a position in Tevogen Bio Holdings in Q3 2025 and held it in 1 quarter.
Arax Advisory Partners's Tevogen Bio Holdings position peaked at $69 in Q3 2025.
51 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.